AI assistant
PTC THERAPEUTICS, INC. — Director's Dealing 2016
Sep 26, 2016
31046_dirs_2016-09-26_ea15369a-0c80-4dc9-b6fd-ac4857becc09.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2016-09-23
Reporting Person: SCHMERTZLER MICHAEL (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-09-23 | Common Stock | M | 60000 | $10.85 | Acquired | 86766 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-09-23 | Stock Option (Right to Buy) | $10.85 | M | 60000 | Disposed | 2023-05-15 | Common Stock (60000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1320369 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $30.86 | 2026-01-03 | Common Stock (24000) | 24000 | Direct |
| Stock Option (Right to Buy) | $51 | 2025-01-01 | Common Stock (24000) | 24000 | Direct |
| Stock Option (Right to Buy) | $27.05 | 2024-01-27 | Common Stock (20000) | 20000 | Direct |
| Stock Option (Right to Buy) | $218.4 | 2022-01-10 | Common Stock (276) | 276 | Direct |
| Stock Option (Right to Buy) | $490.8 | 2021-04-27 | Common Stock (276) | 276 | Direct |
| Stock Option (Right to Buy) | $1149.6 | 2020-02-02 | Common Stock (216) | 216 | Direct |
| Stock Option (Right to Buy) | $508.8 | 2019-10-07 | Common Stock (266) | 266 | Direct |
| Stock Option (Right to Buy) | $735.6 | 2018-01-25 | Common Stock (166) | 166 | Direct |
| Stock Option (Right to Buy) | $735.6 | 2018-07-14 | Common Stock (83) | 83 | Direct |
| Stock Option (Right to Buy) | $626.4 | 2017-04-18 | Common Stock (125) | 125 | Direct |
Footnotes
F1: Represents 86,766 shares of common stock of the Issuer ("common stock") directly held by the reporting person.
F2: Represents shares of common stock held by Section Six Partners, L.P. The reporting person is a general and limited partner of, and trustee of certain family trusts holding interests in, Section Six Partners, L.P. The reporting person disclaims beneficial ownership of the shares of common stock held by Section Six Partners, L.P. except to the extent of his pecuniary interest therein.
F3: Currently exercisable.
F4: This option was awarded on January 4, 2016 and vests over one year in twelve equal monthly installments, commencing February 4, 2016.